Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

There is endless profit potential to treat chronic diseases

Hans Duvefelt, MD
Conditions
August 8, 2020
Share
Tweet
Share

I have noticed several articles describing how antibiotic development has bankrupted some pharmaceutical companies because there isn’t enough potential profit in a ten-day course to treat multi-resistant superbug infections.

Chronic disease treatments, on the other hand, appear to be extremely profitable. A single month’s treatment with the newer diabetes drugs, COPD inhalers, or blood thinners costs over $500, which means well over $50,000 over an effective ten year patent for each one of an ever-increasing number of chronically ill patients.

Imagine if the same bureaucratic processes insurance companies have created for chronic disease drug coverage existed (I don’t know if they do) for acute prescriptions of superbug antibiotics: It’s Friday afternoon, and a septic patient’s culture comes back indicating that the only drug that would work is an expensive one that requires a prior authorization. Patients would die, and the insurance companies would be better off if time ran out in such bureaucratic battles for survival.

Suddenly it’s perfectly clear: There is endless profit potential for countless corporations in America’s chronic disease epidemic, and it is in their interest that people with chronic disease stay as sick as possible without dying from their disease. Why risk research money on acute disease when there is no continuing revenue stream to look forward to?

If people did all the things we know could improve their health, pharmaceutical companies, insurance companies, pharmacy benefit managers, and many others would go out of business, just like shopping malls and print media companies.

Where are the disrupters in health care? Will the perverse motives of the sick care industry create a public uproar? Will the old system someday finally crumble?

Now, I’m just a country doctor, but I’m starting to wonder if a system like the one we have can really continue to function much longer.

Hans Duvefelt is a family physician who blogs at A Country Doctor Writes: and the author of A Country Doctor Writes: CONDITIONS: Diseases and Other Life Circumstances.

Image credit: Shutterstock.com

Prev

The impact of COVID on the Hispanic community [PODCAST]

August 7, 2020 Kevin 0
…
Next

Choice is a charged word in medicine

August 8, 2020 Kevin 1
…

Tagged as: Primary Care, Public Health & Policy

Post navigation

< Previous Post
The impact of COVID on the Hispanic community [PODCAST]
Next Post >
Choice is a charged word in medicine

ADVERTISEMENT

More by Hans Duvefelt, MD

  • The art of asking where it hurts

    Hans Duvefelt, MD
  • Thinking like a plumber when adjusting medications

    Hans Duvefelt, MD
  • The American food conspiracy

    Hans Duvefelt, MD

Related Posts

  • Using low-dose naltrexone to treat pain

    Alex Smith
  • 5 hidden consequences of chronic pain

    Toni Bernhard, JD
  • On the internet, you are looking for something to make you angry

    Judson Ellis
  • Chronic disease is making medical education worse

    Jason J. Han, MD
  • As a medical student, you find potential patients everywhere

    Daniel Azzam and Ajay N. Sharma
  • 5 things I wish I had known earlier about chronic pain

    Tom Bowen

More in Conditions

  • A poem on kidney cancer survivorship and the annual scan

    Michele Luckenbaugh
  • Hashimoto’s disease in adolescent girls: Why it’s often overlooked

    Callia Georgoulis
  • Why doctors ignore their own advice on hydration and health

    Amanda Shim, MD
  • Low testosterone in men: a doctor’s guide to TRT safety

    Martina Ambardjieva, MD, PhD
  • Uterine aging in IVF: Why the “soil” matters as much as the seed

    Oluyemisi Famuyiwa, MD
  • How modern health care design strains patients and clinicians

    Deanna J. Gilmore, RDH
  • Most Popular

  • Past Week

    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
    • The elephant in the room: Why physician burnout is a relationship problem

      Tomi Mitchell, MD | Physician
    • ADHD and cannabis use: Navigating the diagnostic challenge

      Farid Sabet-Sharghi, MD | Conditions
    • Leading with love: a physician’s guide to clarity and compassion

      Jessie Mahoney, MD | Physician
    • Urological analysis of delayed cancer diagnoses in political figures [PODCAST]

      The Podcast by KevinMD | Podcast
    • The economics of prevention: Why an ounce is worth a pound

      Joshua Mirrer, MD | Conditions
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Why PBM transparency rules aren’t enough to lower drug prices

      Armin Pazooki | Policy
    • Clinical attachment in medicine: How familiarity creates safety

      Nesrin Abu Ata, MD | Physician
    • Racial disparities in pancreatic cancer screening cost Black lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • A poem on kidney cancer survivorship and the annual scan

      Michele Luckenbaugh | Conditions
    • AI-enabled clinical data abstraction: a nurse’s perspective

      Pamela Ashenfelter, RN | Tech
    • Why clinical excellence isn’t enough to sustain a physician-owned hospital

      Dr. Bhavin P. Vadodariya | Physician

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Alex Pretti: a physician’s open letter defending his legacy

      Mousson Berrouet, DO | Physician
    • The elephant in the room: Why physician burnout is a relationship problem

      Tomi Mitchell, MD | Physician
    • ADHD and cannabis use: Navigating the diagnostic challenge

      Farid Sabet-Sharghi, MD | Conditions
    • Leading with love: a physician’s guide to clarity and compassion

      Jessie Mahoney, MD | Physician
    • Urological analysis of delayed cancer diagnoses in political figures [PODCAST]

      The Podcast by KevinMD | Podcast
    • The economics of prevention: Why an ounce is worth a pound

      Joshua Mirrer, MD | Conditions
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Physician on-call compensation: the unpaid labor driving burnout

      Corinne Sundar Rao, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Why PBM transparency rules aren’t enough to lower drug prices

      Armin Pazooki | Policy
    • Clinical attachment in medicine: How familiarity creates safety

      Nesrin Abu Ata, MD | Physician
    • Racial disparities in pancreatic cancer screening cost Black lives [PODCAST]

      The Podcast by KevinMD | Podcast
    • A poem on kidney cancer survivorship and the annual scan

      Michele Luckenbaugh | Conditions
    • AI-enabled clinical data abstraction: a nurse’s perspective

      Pamela Ashenfelter, RN | Tech
    • Why clinical excellence isn’t enough to sustain a physician-owned hospital

      Dr. Bhavin P. Vadodariya | Physician

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

There is endless profit potential to treat chronic diseases
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...